Trials / Completed
CompletedNCT00116207
An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes
Oxidative Stress and Cardiovascular Denervation in Diabetes: An Interventional Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The focus of this project is cardiovascular diabetic autonomic neuropathy (DAN). DAN affects the nerves that control heart rate and blood flow to the heart in people with diabetes. DAN may cause problems with the rhythm of the heartbeat or decrease blood flow to the heart. Three medications will be tested for their effectiveness in DAN.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ORAL ANTIOXIDANT | Comparison of triple antioxidant combination therapy vs placebo. |
Timeline
- Start date
- 2000-01-01
- Primary completion
- 2009-09-01
- Completion
- 2009-12-01
- First posted
- 2005-06-28
- Last updated
- 2016-07-29
- Results posted
- 2016-01-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00116207. Inclusion in this directory is not an endorsement.